Blog
RSS FeedPosted by Michael Wonder on 20 Apr 2017
CADTH recommends Kevzara
18 April 2017 - Sarilumab was approved by Health Canada on 12 Jan 2017 for the treatment of adult patients ...
Posted by Michael Wonder on 27 Mar 2017
CADTH recommends Teva's Cinqair
22 March 2017 - Recommendation states price needs to be reduced by 90%. ...
Posted by Michael Wonder on 23 Mar 2017
CADTH recommends reimbursement of Stelara for new indication
21 March 2017 - The cost of treatment with ustekinumab should not exceed the drug plan cost of the least costly ...
Posted by Michael Wonder on 16 Mar 2017
Call for feedback: new drugs for type 2 diabetes: second-line therapy : a therapeutic review update
15 March 2017 - A report on new drugs for second-line therapy for 2 diabetes: a therapeutic review update is now ...
Posted by Michael Wonder on 30 Jan 2017
CADTH recommends UCB's Brivlera
25 January 2017 - CADTH's first outcome for 2017 is in favour of the reimbursement of brivaracetam. ...
Posted by Michael Wonder on 23 Nov 2016
CADTH recommends listing of Quinsair
23 November 2016 - CADTH recommends use of levofloxacin inhalation solution. ...
Posted by Michael Wonder on 02 Nov 2016
Jardiance recommended by CADTH for use by patients with type 2 diabetes mellitus at high risk of cardiovascular disease
26 October 2016 - CADTH publishes final recommendation on prevention of cardiovascular mortality in type 2 diabetes mellitus. ...
Posted by Michael Wonder on 01 Nov 2016
CADTH supports the use of Entyvio in Crohn's disease
31 October 2016 - Takeda's Entyvio clocks up another CADTH recommendation. ...
Posted by Michael Wonder on 30 Oct 2016
CADTH recommends the reimbursement of Taltz
25 October 2016 - The CADTH CDEC has recommend that ixekizumab be reimbursed for patients with moderate to severe plaque ...
Posted by Michael Wonder on 01 Oct 2016
CADTH publishes initial recommendation for Afinitor (everolimus)
29 September 2016 - CADTH has published its initial recommendtation for Novartis' Afinitor. ...
Posted by Michael Wonder on 24 Sep 2016
CADTH publishes final recommendation for Lenvima (lenvatinib mesylate)
20 September 2016 - CADTH has posted its final outcome for Eisai's Lenvima. ...
Posted by Michael Wonder on 30 Aug 2016
CADTH recommends Brilinta (ticagrelor)
25 August 2016 - CADTH has recommended the reimbursement of AstraZeneca's Brilinta (ticagrelor) for the secondary prevention of atherothrombotic events. ...
Posted by Michael Wonder on 30 Aug 2016
CADTH recommends the reimbursement of Invokamet (canagliflozin hemihydrate with metformin hydrochloride)
25 August 2016 - CADTH has published its final recommendation on the reimbursement of Invokamet in Canada. ...
Posted by Michael Wonder on 29 Aug 2016
CADTH recommends against the reimbursement of Egrifta (tesamorelin acetate)
24 August 2016 - CADTH is not convinced that Egrifta should be reimbursed in Canada. ...
Posted by Michael Wonder on 29 Aug 2016
CADTH recommends the reimbursement of Descovy (emtricitabine with tenofovir alafenamide fumarate)
24 August 2016 - CADTH is in favour of the reimbursement of Gilead's new dual combination product for HIV-1 infection. ...